Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy using cardiovascular magnetic resonance by Rory O'Hanlon et al.
BioMed Central
Page 1 of 1
(page number not for citation purposes)
Journal of Cardiovascular Magnetic 
Resonance
Open AccessOral presentation
Prognostic significance of myocardial fibrosis in hypertrophic 
cardiomyopathy using cardiovascular magnetic resonance
Rory O'Hanlon*1, Agata Grasso1, Michael Roughton2, James C Moon3, 
Susan Clarke1, Ricardo Wage1, Jess Webb1, Meghana Kulkarni1, 
Dana Dawson1, Leena Sulaibeekh1, Bud Chandrasekaran1, Chiara Bucciarelli-
Ducci1, Ferdinando Pasquale3, Martin R Cowie4, Wiliam J McKenna3, 
Margaret Burke5, Mary Sheppard1, Perry M Elliot3, Dudley J Pennell1 and 
Sanjay K Prasad1
Address: 1Royal Brompton Hospital, London, UK, 2R-Squared Statistics, London, UK, 3The Heart Hospital, London, UK, 4Imperial College, 
London, UK and 5Harefield Hospital, London, UK
* Corresponding author    
Introduction
The role of myocardial fibrosis in the prediction of sudden
death and heart failure in hypertrophic cardiomyopathy
(HCM) is unclear.
Purpose
We sought to investigate the prognostic significance of
fibrosis detection by cardiovascular magnetic resonance
(CMR) to predict major clinical events in HCM using the
late gadolinium-enhanced (LGE) technique.
Methods
A prospective cohort study of 217 consecutive HCM
patients followed for 3.1 + 1.7 years to determine the role
of fibrosis detected using LGE-CMR on morbidity and
mortality.
Results
LGE was present in 136/217 (LGE+, 63%). Thirty four of
the 136 patients (25%) in the LGE+ group and 6/81
(7.4%) in the LGE- group reached the combined primary
endpoint of cardiovascular death, unplanned cardiovas-
cular admission, sustained VT/VF, or appropriate ICD dis-
charge, (HR 3.4, p = 0.006). In the LGE+ group, overall
risk increased with the percentage of LGE present (HR
1.03 per percent LGE increase, p = 0.008). The risk of
unplanned heart failure admissions, deterioration to
NYHA III or IV, or heart failure related death was greater
in LGE+ group (HR 2.5, p = 0.021), and this risk increased
as the percentage of LGE increased (HR 1.03 per percent
LGE increase, p = 0.017). All relationships remained sig-
nificant after multivariate analysis. The overall percentage
of LGE was an important univariate predictor for arrhyth-
mic endpoints (sustained VT/VF, appropriate ICD dis-
charge, SCD), HR 1.05 per percent LGE increase, p =
0.014), but did not reach significance after multivariate
analysis.
Conclusion
In patients with HCM, myocardial fibrosis is an independ-
ent predictor of adverse outcome particularly due to heart
failure
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